Clinical Trial Update: Effect of Antineoplaston Therapy on the QT/QTc Interval In Subjects With Diffuse, Intrinsic, Brainstem Glioma [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating the effect of antineoplaston therapy on QT/QTc interval in patients with diffuse intrinsic pontine glioma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diffuse Intrinsic Pontine Glioma

Drugs mentioned

• Antineoplaston therapy

Snippet

Sponsor: Burzynski Research Institute | Conditions: Brain Stem Glioma | Phase 3 | Status: NOT_YET_RECRUITING